Medicine
from24/7 Wall St.
6 days agoBiomarin Up After Q3 Earnings: Here's Everything You Need to Know
BioMarin missed quarterly earnings and revenue estimates but generated strong operating cash flow, strengthened cash reserves, and saw double-digit revenue growth from VOXZOGO and PALYNZIQ.